Status:

COMPLETED

Post-Market Study of the 3DKnee™ System

Lead Sponsor:

Encore Medical, L.P.

Conditions:

Degenerative Joint Disease

Osteoarthritis

Eligibility:

All Genders

18+ years

Brief Summary

The purpose of this study is to evaluate the use and efficacy of the 3DKnee™ System for total knee replacement surgery.

Detailed Description

Total knee replacement surgery is widely accepted as effective treatment for degenerative joint disease (DJD), osteoarthritis and rheumatoid arthritis. Relief of patient pain and return of mobility ar...

Eligibility Criteria

Inclusion

  • This must be a primary knee replacement on this knee.
  • Patient is over 18 years of age or older
  • Have knee joint disease related to one or more of the following
  • degenerative joint disease, including osteoarthritis or traumatic arthritis
  • Avascular necrosis of the femoral condyles
  • Post-traumatic loss of joint configuration, particularly when there is patellofemoral erosion, dysfunction or prior patellectomy
  • Moderate valgus, varus, or flexion deformities
  • Rheumatoid arthritis
  • Patient is likely to be available for evaluation for the duration of the study
  • Able and willing to sign the informed consent and follow study procedures
  • Patient is not pregnant

Exclusion

  • Is younger than 18 years of age
  • If there has been a total knee replacement on this knee in the past (no revisions allowed in study)
  • Infection, or history of infection, acute or chronic, local or systemic
  • Alcoholism or other addictions
  • Muscular, neurological or vascular deficiencies which compromise the affected extremity
  • Obesity
  • Insufficient bone quality
  • Loss of ligamentous structures
  • High levels of physical activity
  • Materials sensitivity
  • Prisoner
  • Mental conditions that may interfere with the patient's ability to give an informed consent or willingness to fulfill the study requirements
  • Patient is pregnant

Key Trial Info

Start Date :

February 1 2009

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

October 1 2018

Estimated Enrollment :

229 Patients enrolled

Trial Details

Trial ID

NCT00819481

Start Date

February 1 2009

End Date

October 1 2018

Last Update

March 16 2021

Active Locations (8)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (8 locations)

1

Longo Orthopedics

Scottsdale, Arizona, United States, 85251

2

Center for Excellence

Fresno, California, United States, 93710

3

OrthoMaryland

Baltimore, Maryland, United States, 21209

4

Metro Orthopedics and Sports Therapy

Silver Spring, Maryland, United States, 20910